BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 1,600 shares, a decrease of 15.8% from the January 31st total of 1,900 shares. Based on an average daily trading volume, of 136,800 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Stock Down 8.4 %

Shares of NASDAQ:BCTXW opened at $0.09 on Friday. BriaCell Therapeutics has a one year low of $0.07 and a one year high of $1.74. The company has a 50-day simple moving average of $0.16 and a 200-day simple moving average of $0.26.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.